Microdosing GLP-1 means using doses significantly below the approved therapeutic range, but this practice lacks clinical trial evidence and is not approved by the MHRA
13, 204 adults who did not take any GLP-1 based medication) with obesity and at least one diagnosed autoimmune condition
Call 999 or go to A&E immediately if itching is accompanied by: Widespread rash or hives (urticaria) covering large areas of the body Swelling of the face, lips, tongue, or throat (angioedema), which may indicate anaphylaxis Difficulty breathing, wheezing, or chest tightness Dizziness, rapid heartbeat, or feeling faint Severe or worsening skin reactions , including blistering, peeling, or painful lesions These symptoms may represent a serious hypersensitivity reaction requiring immediate cessation of Mounjaro and emergency medical intervention
Keep in mind, the following pointers are general clinical information and not a substitute for individualized medical advice from your prescriber